Human cytomegalovirus (CMV) infection is common and usually results in a mild, non-specific illness in otherwise healthy individuals followed by asymptomatic latency. However, congenital CMV...
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
The use of adeno-associated viruses (AAV) as gene delivery vectors has vast potential for the treatment of many severe human diseases. A small group of intensively studied AAV capsids have b...
Learning Objectives: - Summarize the reasons for growth of Precision Medicine-based testing - Review challenges that are impacting the growth of Precision Medicine - Identify opportunities t...
The human genome project was undertaken to determine the human DNA sequence and analyze variation among individuals. To make use of this information, tools were developed that could collect...
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
Prompt and early diagnosis of sexually transmitted infections (STIs) is important to enable appropriate treatment and help prevent further transmission. Clinical testing labs require STI tes...
In the emergency department, distinguishing between bacterial and viral infections can be challenging, leading to inappropriate use of antibiotics that may contribute to the development of b...
Real-time PCR, also known as quantitative PCR (qPCR), is the gold standard for sensitive, specific detection and quantification of nucleic acid targets. This qPCR technology as offered by Th...
Participate in this educational webinar to learn about key objects in Treponemal screening. Today's presentation will cover the following topics from the perspective of a NYC based Labor...
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...
Date: April 20, 2023 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) A recent systematic review found that more than half of known infectious diseases will be aggravated by climate hazards,...
Date: April 18, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Whilst a decade ago the prognosis of lung cancer patients has been very disappointing, nowadays a substantial evolutio...
Date: April 11, 2023 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Antimicrobial resistant (AMR) infections are on the rise causing approximately 1.3M deaths each year due to patients suc...
Date: April 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Duchenne muscular dystrophy is caused by mutations in the dystrophin encoding DMD gene that disrupt the reading frame. M...
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the...
Date: March 30, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Join the Gibco Cell Culture Heroes webinar featuring Heather Beasley, PhD as she presents "SLC25A46 as a Novel Mitoc...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms ...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Human cytomegalovirus (CMV) infection is common and usually results in a mild, non-specific illness in otherwise healthy individuals followed by asymptomatic latency. However, congenital CMV...
Cell-based immunotherapy has become the new-generation cancer medicine, and “off-the-shelf” cell products that can be manufactured at large scale and distributed readily to treat...
The use of adeno-associated viruses (AAV) as gene delivery vectors has vast potential for the treatment of many severe human diseases. A small group of intensively studied AAV capsids have b...
Learning Objectives: - Summarize the reasons for growth of Precision Medicine-based testing - Review challenges that are impacting the growth of Precision Medicine - Identify opportunities t...
The human genome project was undertaken to determine the human DNA sequence and analyze variation among individuals. To make use of this information, tools were developed that could collect...
Liquid biopsies represent a transformation in the management of cancer as they have the potential to detect, characterize, and monitor cancers earlier than can be achieved with conventional...
Prompt and early diagnosis of sexually transmitted infections (STIs) is important to enable appropriate treatment and help prevent further transmission. Clinical testing labs require STI tes...
In the emergency department, distinguishing between bacterial and viral infections can be challenging, leading to inappropriate use of antibiotics that may contribute to the development of b...
Real-time PCR, also known as quantitative PCR (qPCR), is the gold standard for sensitive, specific detection and quantification of nucleic acid targets. This qPCR technology as offered by Th...
Participate in this educational webinar to learn about key objects in Treponemal screening. Today's presentation will cover the following topics from the perspective of a NYC based Labor...
Date: April 25, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) A liquid biopsy is a non-invasive alternative to a surgical biopsy that enables researchers to learn a range of infor...
Date: April 20, 2023 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) A recent systematic review found that more than half of known infectious diseases will be aggravated by climate hazards,...
Date: April 18, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Whilst a decade ago the prognosis of lung cancer patients has been very disappointing, nowadays a substantial evolutio...
Date: April 11, 2023 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEST) Antimicrobial resistant (AMR) infections are on the rise causing approximately 1.3M deaths each year due to patients suc...
Date: April 11, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Duchenne muscular dystrophy is caused by mutations in the dystrophin encoding DMD gene that disrupt the reading frame. M...
Dr. Ritterhouse's laboratory has implemented rapid and ultra rapid protocol for NSCLC genomic profiling, based on NGS. This has led to significant shortening of turn around time (TAT) an...
This talk will highlight key changes to the various guidelines in myeloid and lymphoid testing, commenting on the current and future landscape of biomarkers. The speakers will then share the...
Date: March 30, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Join the Gibco Cell Culture Heroes webinar featuring Heather Beasley, PhD as she presents "SLC25A46 as a Novel Mitoc...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms...
Clinical laboratories worldwide are implementing various targeted panels to identify cancer genomic variants and ultimately improve patient outcomes. As most of the panels and NGS platforms ...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...
Next-generation sequencing can detect multiple driver oncogenes simultaneously, enabling the analysis of limited amounts of biopsied tissue samples. . Druggable driver mutations cover more t...